Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Tirzepatide (Zepbound, FDA-approved for weight management) functions as both a GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist
Weight bias and health care utilization: a scoping review
Availability of retatrutide will depend on the completion of trials and FDA approval, which could take some time
For most patients, this small increase carries little or no consequence
I was not sold on the idea of using Amylin agonism as a weight loss medicine
Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity
US$ 29.49
US$ 28.81
US$ 23.28
US$ 24.69
US$ 25.51
US$ 24.21
US$ 24.00
